63,768 Shares in Cardinal Health, Inc. $CAH Purchased by Navellier & Associates Inc.

Key Points

• Navellier & Associates bought 63,768 shares of Cardinal Health (NYSE:CAH) in Q4, a roughly $13.1 million position that represents 1.5% of its portfolio and is its 13th-largest holding.
• Institutional ownership is high at 87.17%, with major managers—including Vanguard (31,441,258 shares), Wellington, Bank of America, Invesco and Victory Capital—adding to their stakes.
• Analysts carry a consensus "Moderate Buy" rating with a $241.80 target; Cardinal Health recently beat EPS ($3.17 vs. $2.79), set FY2026 guidance of $10.70–10.80, and raised its quarterly dividend to $0.5158 (annualized $2.06, ~1.0% yield).

Navellier & Associates Inc. acquired a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 63,768 shares of the company's stock, valued at approximately $13,104,000. Cardinal Health accounts for 1.5% of Navellier & Associates Inc.'s portfolio, making the stock its 13th biggest position.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in shares of Cardinal Health by 2.0% in the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company's stock valued at $6,461,179,000 after purchasing an additional 617,775 shares during the period. Wellington Management Group LLP increased its stake in shares of Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company's stock valued at $911,010,000 after purchasing an additional 3,511,579 shares during the period. Bank of America Corp DE increased its stake in shares of Cardinal Health by 3.2% in the third quarter. Bank of America Corp DE now owns 3,592,775 shares of the company's stock valued at $563,922,000 after purchasing an additional 111,582 shares during the period. Invesco Ltd. increased its stake in shares of Cardinal Health by 14.7% in the third quarter. Invesco Ltd. now owns 3,483,207 shares of the company's stock valued at $546,724,000 after purchasing an additional 445,425 shares during the period. Finally, Victory Capital Management Inc. increased its stake in shares of Cardinal Health by 44.9% in the third quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company's stock valued at $352,165,000 after purchasing an additional 707,495 shares during the period. Institutional investors and hedge funds own 87.17% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Mizuho raised their price target on shares of Cardinal Health from $222.00 to $235.00 and gave the company an "outperform" rating in a research note on Friday, February 6th. Evercore dropped their price target on shares of Cardinal Health from $260.00 to $240.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 8th. Jefferies Financial Group raised their price target on shares of Cardinal Health from $220.00 to $270.00 and gave the company a "buy" rating in a research note on Thursday, January 22nd. Barclays increased their price objective on shares of Cardinal Health from $243.00 to $258.00 and gave the company an "overweight" rating in a report on Tuesday, February 24th. Finally, Wells Fargo & Company decreased their price objective on shares of Cardinal Health from $256.00 to $245.00 and set an "overweight" rating for the company in a report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $241.80.

Cardinal Health Price Performance

Cardinal Health stock opened at $196.97 on Wednesday. The firm has a 50 day simple moving average of $213.19 and a 200-day simple moving average of $206.47. The stock has a market capitalization of $46.13 billion, a PE ratio of 30.12, a price-to-earnings-growth ratio of 1.17 and a beta of 0.53. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. The business had revenue of $60.94 billion during the quarter, compared to analysts' expectations of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business's revenue was up 11.0% on a year-over-year basis. During the same period last year, the firm posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, analysts forecast that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. The ex-dividend date is Wednesday, July 1st. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a yield of 1.0%. Cardinal Health's payout ratio is 31.19%.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.